Compare
Illumina, Inc. vs Bruker Corp vs Waters Corp vs Avantor, Inc.
| Latest fiscal year | Illumina, Inc. ILMN | Bruker Corp BRKR | Waters Corp WAT | Avantor, Inc. AVTR |
|---|---|---|---|---|
| Year ended | 2025-12-28 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $4.34B | $3.44B | $3.17B | $6.55B |
| Revenue growth (YoY) | -0.7% | +2.1% | +7.0% | -3.4% |
| Gross margin | 66.1% | 45.9% | 59.3% (computed) | 32.7% |
| Operating margin | 18.6% | 2.0% | 25.4% | -3.8% |
| Net margin | 19.6% | -0.2% | 20.3% | -8.1% |
| Net income | $850.00M | -$8.30M | $642.63M | -$530.20M |
| EPS (Diluted) | $5.45 | -$0.15 | $10.76 | -$0.78 |
| Operating cash flow | $1.08B | $134.10M | $652.55M | $623.80M |
| Free cash flow | $931.00M | $43.30M | $539.81M | $495.00M |
| Cash & equivalents | n/a | $298.80M | $587.83M | $365.40M |
| Total assets | $6.64B | $6.24B | $5.08B | $11.79B |
| Total liabilities | n/a | $3.73B | $2.52B | $6.23B |
| Shareholders' equity | $2.72B | $2.47B | $2.56B | $5.57B |
| Return on year-end equity | 31.2% | -0.3% | 25.1% | -9.5% |
| Shares outstanding | 153.00M | 152.14M | 59.55M | 682.00M |
Revenue, most recent five fiscal years
| Fiscal year | Illumina, Inc. | Bruker Corp | Waters Corp | Avantor, Inc. |
|---|---|---|---|---|
| Latest | $4.34B Ended 2025-12-28 | $3.44B Ended 2025-12-31 | $3.17B Ended 2025-12-31 | $6.55B Ended 2025-12-31 |
| 1 year earlier | $4.37B Ended 2024-12-29 | $3.37B Ended 2024-12-31 | $2.96B Ended 2024-12-31 | $6.78B Ended 2024-12-31 |
| 2 years earlier | $4.50B Ended 2023-12-31 | $2.96B Ended 2023-12-31 | $2.96B Ended 2023-12-31 | $6.97B Ended 2023-12-31 |
| 3 years earlier | $4.58B Ended 2023-01-01 | $2.53B Ended 2022-12-31 | $2.97B Ended 2022-12-31 | $7.51B Ended 2022-12-31 |
| 4 years earlier | $4.53B Ended 2022-01-02 | $2.42B Ended 2021-12-31 | $2.79B Ended 2021-12-31 | $7.39B Ended 2021-12-31 |